Venous thromboembolic disease: Clinical Practice Guidelines in Oncology Review uri icon

Overview

MeSH Major

  • Neoplasms
  • Venous Thromboembolism

abstract

  • Venous thromboembolism (VTE) remains a common and life-threatening complication among patients with cancer. Thromboprophylaxis can be used to prevent the occurrence of VTE in patients with cancer who are considered at high risk for developing this complication. Therefore, it is critical to recognize the various risk factors for VTE in patients with cancer. Risk assessment tools are available to help identify patients for whom discussions regarding the potential benefits and risks of thromboprophylaxis would be appropriate. The NCCN Clinical Practice Guidelines in Oncology for VTE provide recommendations on risk evaluation, diagnosis, prevention, and treatment of VTE in patients with cancer.

publication date

  • November 2013

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 24225973

Additional Document Info

start page

  • 1402

end page

  • 29

volume

  • 11

number

  • 11